Efficacy of Ustekinumab combined with partial enteral nutrition in Crohn's disease.

Front Nutr · 2026 · PMC13229795 · PMID 42245560

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

The results showed that UST combined with PEN exhibited a positive trend toward higher endoscopic remission rates across all strata of baseline characteristics (all subgroup ORs > 1), and the benefit of the combined therapy was statistically significant in patients aged ≥30 years [OR 3.64 (95% CI 1.26–10.51), p = 0.0169].

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.